Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-004402

Chief Scientific Officer gave up 21,283 shares (to pay taxes)

  • Chief Scientific Officer acquired 73,425 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2024-03-01 Option exercise +50,000 184,641 D: show line 1 in the form
Monahan Joseph Chief Scientific Officer 2024-03-01 Shares withheld for taxes −14,569 $1.24 $18,066 170,072 D: show line 2 in the form
Monahan Joseph Chief Scientific Officer 2024-03-01 Option exercise +10,925 180,997 D: show line 3 in the form
Monahan Joseph Chief Scientific Officer 2024-03-01 Shares withheld for taxes −3,183 $1.24 $3,947 177,814 D: show line 4 in the form
Monahan Joseph Chief Scientific Officer 2024-03-02 Option exercise +12,500 190,314 D: show line 5 in the form
Monahan Joseph Chief Scientific Officer 2024-03-02 Shares withheld for taxes −3,531 $1.24 $4,378 186,783 D: show line 6 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2024-03-01 Option exercise · Restricted Stock Units −50,000 50,000 D: show line 7 in the form
Monahan Joseph Chief Scientific Officer 2024-03-01 Option exercise · Restricted Stock Units −10,925 21,850 D: show line 8 in the form
Monahan Joseph Chief Scientific Officer 2024-03-02 Option exercise · Restricted Stock Units −12,500 0 D: show line 9 in the form
Loading xslF345X05/doc4.xml…